Clachar HG, Araque AB

Idioma: Español
Referencias bibliográficas: 22
Paginas: 79-84
Archivo PDF: 172.74 Kb.

RESUMEN

La HPP es una emergencia obstétrica que puede presentarse luego del parto vaginal o cesárea, siendo la causa de mortalidad más importante en el mundo. Tradicionalmente se ha definido la HPP como la pérdida estimada de sangre de 500 ml o más luego del parto vaginal, o igual o más de 1000 ml después de un parto por cesárea. A nivel clínico la HPP se ha definido como el sangrado excesivo que se torna al paciente sintomático y la presencia de signos de hipovolemia como la hipotensión, taquicardia, oliguria, y disminución de la saturación de oxígeno por debajo de 95%. Como nemotecnia se describen cuatro “T”: tono, tejidos, trauma y trombina. El punto más importante del tratamiento de la HPP es predicción y prevención. La atonía uterina es a causa de hemorragia más frecuente, el objetivo de las primeras intervenciones es asegurar la contracción del útero.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Abou Zahr C. Global burden of maternal death and disability. Br Med Bull 2003; 67:1–11.

2. American College of Obstetricians, Gynecologists. American College of Obstetrics and Gynecology practice bulletin: clinical management guidelines for obstetriciangynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039–47.

3. Anderson J, Etches D, Smith D. Postpartum hemorrhage. In: Baxley E, editor. Advanced life support in obstetrics course syllabus. 4th Edition. Leawood (KS): American Academy of Family Physicians; 2001.

4. Andolina K, Daly S, Roberts N, et al. Objective measurement of blood loss at delivery: is it more than a guess? Am J Obstet Gynecol 1999; 180: S69. 7

5. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69– 76.

6. Christianson LM, Bovbjerg VE, McDavitt EC, et al. Risk factors for perineal injury during delivery. Am J Obstet Gynecol 2003; 189: 255- 60.

7. Devine PC. Obstetric hemorrhage. Semin Perinatol 2009; 33: 76- 81.

8. Jackson KW Jr, Allbert JR, Schemmer GK, et al. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 2001; 185: 873 - 7.

9. Jansen AJ, Rhenen DJ, Steegers EA, et al. Postpartum hemorrhage and transfu-sion of blood and blood components. Obstet Gynecol Surv 2005; 60:663- 71.

10. Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997:104: 803-10.

11. Kadir RA, Lee CA, Sabin CA, et al. Pregnancy in women with von Willebrand’s disease or factor XI deficiency. Br J Obstet Gynaecol 1998;105: 314- 21.

12. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066- 74.

13. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008;14: 171- 232

14. Oyelese Y, Mastrolia R. Postpartum Hemorrhage. Obstet Gynecol Clin N Am 34 (2007) 421– 441.

15. Pritchard JA, Baldwin RM, Dickey JC, et al. Blood volume changes in pregnancy and the puerperium. II. Red blood cell loss and changes inapparent blood volume during and followng vaginal delivery, cesarean section, and cesarean section plus total hysterectomy. Am J Obstet Gynecol 1962;84: 1271- 82.

16. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour [review]. Cochrane Database Syst Rev 2000; 3: CD000007.

17. Rajan PV, Wing DA. Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 2010; 53: 165- 81.

18. Rouse DJ, Landon M, Leveno KJ, et al. The maternalfetal medicine units cesarean registry: chorioamnionitis at term and its duration relationship to outcome. Am J Obstet Gynecol 2004; 191:211- 6.

19. Rouse DJ, Leindecker S, Landon M, et al. The MFMU cesarean registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol 2005; 193: 1056 -60.

20. Silver RM, Major H. Maternal coagulation disorders and 84 REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA postpartum hemorrhage. Clin Obstet Gynecol 2010; 53:252- 64.

21. Stones RW, Paterson CM, Saunders NJ. Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 1993; 48:15- 8.

22. World Health Organization (WHO) Department of Reproductive Health and Research. Maternal mortality in 2005: estimates developed by WHO, UNICEF, and UNFPA. Geneva (Switzerland): WHO; 2005.